Updates
Follow the evidence, not the hype.
One email when something actually changes — a new study, a safety note, a regulatory move, a tier change, or a fresh claim check. No spam, no protocols, no sales.
What we'll sendNew human study
When a real human trial lands for a tracked compound.
Safety update
New or revised safety signals worth knowing.
Regulatory change
FDA / international status changes.
Tier changed
When the evidence moves a compound up or down.
New claim check
When a popular claim gets audited against the data.
Prefer to follow one compound? Open any peptide page and use “Follow updates.”
Research reference only. Not medical advice. We never sell or share your email.